I mean, it just that, that, that whole summary just kind of underscores how complex and opaque The drug pricing and drug supply chain system is complex and opaque. that's one thing we learned from the work of the task force is, you know, as public policymakers and regulators, it's difficult to understand where to focus on the supply chain. (31:44–31:59)
CLAIM
Asserts that the drug pricing and supply chain system lacks transparency and is difficult to understand.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
